Fortbildung bei der DGRA e.V.


Therapeutische Vaccine

27. November 2012 in Bonn


Dienstag, 27. November 2012 | 10.00 Uhr bis 16.30 Uhr Termin in den eigenen Kalender übertragen


Wissenschaftszentrum Bonn
Ahrstraße 45, 53175 Bonn
Tel.: 0228 - 30 20

  • Programmvorschau Änderungen vorbehalten

    Programm am 27. November 2012

    10.00 I. Breaking tolerance, pre-requisite for the development of therapeutic vaccines - 
      new approaches in vaccine development. How we meet regulatory requirements
      Point out the immunological challenge with therapeutic vaccines
    • “autologous” antigen – breaking tolerance
    • Autoimmunity
    • Role of innate immune response
    • Role of cellular immune response
      Immune modulators
    • Own platform technology
    Dr. Matthias Schroff, Mologen AG
    10.45 Coffee Break
    11.15 II. Approved veterinary vaccines paving the way
      for the development of human therapeutic vaccines?
    Current status of approved therapeutic vaccines in the veterinary field
      Equine Arteritis Virus-Vaccine
    • Disease characteristic and vaccine design
    • Impact for human medicine
      Canine Melanoma Vaccine
    • Biology of canine melanoma
    • The vaccine
    • Impact for human medicines
    Dr. Matthias Giese, Institute for Molecular Vaccines
    12.00 III. Clinical development of therapeutic cancer vaccines
    • Clinical development of a human anticancer vaccine (Presentation will be tailored upon the request)
    PhD MD Patrick Therasse, Vice President GlaxoSmithKline Biologicals
    12.45 Lunch Break
    13.45 IV. Challenges in the clinical development of cancer vaccines – Regulators perspective
      Translation from non-clinical to clinical data-what are the challenges
    • Impact of the natural course of the disease on the clinical development
    • What can we expect from a tumour vaccine
      Clinical trials (EMA and FDA guidelines)
    • Patients populations
    • Endpoints
    Dr. Bridget Heelan, MHR
    14.30  Coffee Break
    15.00 V. HIV Therapeutic Vaccine Shows Signs of Promise
    • Objectives of a therapeutic HIV vaccines
    • Preliminary Results (presented in Bangkok)
    Prof. Dr. Jürgen Rockstroh, Uniklinik Bonn
    15.45 VI. The place of a therapeutic HIC vaccine in the toolbox for HIV treatments
    • Goals to archive with the vaccine
    • Safety and efficacy requirements
    • Clinical trial issues ~ how to select the clinical trial population
    Dr. Nathalie Morgensztejn, National Agency of Medicine and Health Product Safety

  • Kostenbeitrag und Stornierungen

    For DGRA members and M.D.R.A. students course XIV:€ € 220,-

    • Up to two weeks before the first day of the conference (13-Nov-12): € 50
    • Up to one week before the first day of the conference (20-Nov-12): 50% of fee
    • Late cancellations: full conference fee if a substitute participant (DGRA member) cannot be put forward.

    In the event of cancellation by the organizer, any fees already paid will be fully reimbursed.

  • Anreise und Unterkunft

    A limited number of rooms are available for participants at special rates in the hotels listed below. When making reservations (up to Nov 9) please refer to DGRA.

    Sternhotel, Bonn-Innenstadt
    Phone: +49 - 228/7 26 70

    Villa Godesberg, Bonn-Bad Godesberg
    Phone: +49 - 228/83 00 60

    More available rooms for direct booking (incl. public transport),

  • Unterlagen Mitgliedern vorbehalten
    Bitte melden Sie sich hier mit Ihren Zugangsdaten an und klicken Sie danach erneut auf Anmeldung.